Patent classifications
D01F6/96
POLYMER FIBRE HAVING IMPROVED DISPERSIBILITY
The invention relates to a polymer fibre with improved dispersibility, a method for producing said fibre and the use of said fibre.
The polymer fibre according to the invention comprises at least one synthetic polymer and 0.1 and 20 wt. % of a silicone. The polymer forming the fibre forms a solid dispersion medium at room temperature (25 C.) for the silicone present in solid form also at room temperature (25 C.) which forms the more disperse phase.
The polymer fibre according to the invention possesses an improved dispersibility and is therefore suitable for producing aqueous suspensions which are used, for example, in the formation of textile fabrics, e.g. nonwovens.
Plant and method for making continuous elastic yarns made of silicone material and continuous elastic yarn made of silicone material thus obtained
A plant and method for making continuous yarns made of silicone material comprises at least an extrusion station, into which the material is introduced in an amorphous condition, and extrusion means which cause the material to exit from the extrusion station along an extrusion axis. The plant also comprises a vulcanization station, located downstream of the extrusion station, at a determinate distance therefrom, in which the continuous yarn is vulcanized in a direction of treatment. The plant also comprises a drawing unit, disposed downstream of the vulcanization station.
Plant and method for making continuous elastic yarns made of silicone material and continuous elastic yarn made of silicone material thus obtained
A plant and method for making continuous yarns made of silicone material comprises at least an extrusion station, into which the material is introduced in an amorphous condition, and extrusion means which cause the material to exit from the extrusion station along an extrusion axis. The plant also comprises a vulcanization station, located downstream of the extrusion station, at a determinate distance therefrom, in which the continuous yarn is vulcanized in a direction of treatment. The plant also comprises a drawing unit, disposed downstream of the vulcanization station.
Method for retrovirus removal
A method for removing retroviruses from liquid samples and a nanofiber containing liquid filtration medium that simultaneously exhibits high liquid permeability and high microorganism retention is disclosed. Retroviruses are removed from a liquid by passing the liquid through a porous nanofiber containing filtration medium having a retrovirus LRV greater than about 6, and the nanofiber(s) has a diameter from about 10 nm to about 100 nm. The filtration medium can be in the form of a fibrous electrospun polymeric nanofiber liquid filtration medium mat.
Method of Forming Prefabricated Units Used in the Production of Systems of Prosthetic Aortic Valve Transcatheter Implantation and a Prosthetic Aortic Valve Prefabricated Unit
A method of forming prefabricated units used in production of systems of prosthetic aortic valve transcatheter implantation and prosthetic aortic valve prefabricated unit with an non-thrombogenic smooth surface layer or with a porous fibrous layer constituting a scaffold for epithelium cell culture, intended for manufacturing TAVI system. Stents for covering and solutions of polycarbonate silicones and/or polycarbonate urethanes and/or polyurethane with average molecular weight in the range from 50,000 g/mol to 200,000 g/mol in the solvent DMAC are prepared. Initially a smooth layer of polycarbonate silicone is applied in the electrospinning machine by electro spraying with use of the solution in DMAC with the concentration of 2-8% w/w. and/or a fiber of polycarbonate urethane is applied by electrospinning on the roller with use of the solution in DMAC with the concentration of 8-20% w/w to obtain the first surface layer, with a specified speed, number of heads, thickness of capillaries, speed of movement, voltage and distance between the capillary and the roller and the specified flow of the solution on the feeding pump and after a certain time the layer covering the roller with thickness of 1-100 m is obtained. Thereafter the inner intermediate layer of polycarbonate silicone is formed by electro spraying. When the thickness of the layer is approximately 5 to 100 m the process is stopped and stents are placed on the formed layer and similarly like applying the former intermediate layer the application of the inner intermediate layer is continued on the whole length of the roller. Thereafter the final surface layer is applied like the first surface layer until a prefabricated unit with the polymer material thickness from 50 to 250 m is obtained.
Method of Forming Prefabricated Units Used in the Production of Systems of Prosthetic Aortic Valve Transcatheter Implantation and a Prosthetic Aortic Valve Prefabricated Unit
A method of forming prefabricated units used in production of systems of prosthetic aortic valve transcatheter implantation and prosthetic aortic valve prefabricated unit with an non-thrombogenic smooth surface layer or with a porous fibrous layer constituting a scaffold for epithelium cell culture, intended for manufacturing TAVI system. Stents for covering and solutions of polycarbonate silicones and/or polycarbonate urethanes and/or polyurethane with average molecular weight in the range from 50,000 g/mol to 200,000 g/mol in the solvent DMAC are prepared. Initially a smooth layer of polycarbonate silicone is applied in the electrospinning machine by electro spraying with use of the solution in DMAC with the concentration of 2-8% w/w. and/or a fiber of polycarbonate urethane is applied by electrospinning on the roller with use of the solution in DMAC with the concentration of 8-20% w/w to obtain the first surface layer, with a specified speed, number of heads, thickness of capillaries, speed of movement, voltage and distance between the capillary and the roller and the specified flow of the solution on the feeding pump and after a certain time the layer covering the roller with thickness of 1-100 m is obtained. Thereafter the inner intermediate layer of polycarbonate silicone is formed by electro spraying. When the thickness of the layer is approximately 5 to 100 m the process is stopped and stents are placed on the formed layer and similarly like applying the former intermediate layer the application of the inner intermediate layer is continued on the whole length of the roller. Thereafter the final surface layer is applied like the first surface layer until a prefabricated unit with the polymer material thickness from 50 to 250 m is obtained.
Nonwoven substrate comprising fibers comprising an engineering thermoplastic polymer
A nonwoven substrate comprising a polyolefin and an engineering thermoplastic polymer. The engineering thermoplastic polymer may be present in the nonwoven substrate at a level of between about 1% and about 20% by weight of the nonwoven substrate. The layer of fibers is free of a compatibilizer.
Process for the production of a formulation containing poly(lactic acid) and aliphatic and/or aromatic polyesters and products using it
The invention presented in this document relates to processes for the preparation of a formulation containing poly(lactic acid) (PLA) and aliphatic and/or aromatic polyesters which plasticize it, and its use in monofilaments and films. The presence of polyesters does not remove the biodegradability and composting characteristics of the raw materials used in the formulation. The invention also concerns products that use the formulation.
Process for the production of a formulation containing poly(lactic acid) and aliphatic and/or aromatic polyesters and products using it
The invention presented in this document relates to processes for the preparation of a formulation containing poly(lactic acid) (PLA) and aliphatic and/or aromatic polyesters which plasticize it, and its use in monofilaments and films. The presence of polyesters does not remove the biodegradability and composting characteristics of the raw materials used in the formulation. The invention also concerns products that use the formulation.